Breast Cancer Update

ResearchToPractice.com/SABCS_2008 – Second Opinion: Proceedings and Interviews from a 2-Part CME Satellite Symposia Held at the 31st Annual San Antonio Breast Cancer Symposium. Case: 49-year-old woman with biopsy-confirmed liver and lung metastases three years after adjuvant AC for a triple-negative IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/SABCS_2008 – Second Opinion: Proceedings and Interviews from a 2-Part CME Satellite Symposia Held at the 31st Annual San Antonio Breast Cancer Symposium. Case: 47-year-old woman with multiple unresectable brain metastases eight years after adjuvant anthracycline/taxane therapy for an ER/PR-negative, HER2-positive IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/SABCS_2008 – Second Opinion: Proceedings and Interviews from a 2-Part CME Satellite Symposia Held at the 31st Annual San Antonio Breast Cancer Symposium. Case: 65-year-old woman with rapidly progressive, symptomatic bone and lung metastases after recurrence during her fifth year of an adjuvant aromatase inhibitor for ER/PR-positive, HER2-negative BC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/SABCS_2008 – Second Opinion: Proceedings and Interviews from a 2-Part CME Satellite Symposia Held at the 31st Annual San Antonio Breast Cancer Symposium. Case: 62-year-old woman with a neglected 6-cm, ER/PR-positive, HER2-positive IDC and biopsy-proven lung metastases who refuses chemotherapy. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/SABCS_2008 – Second Opinion: Proceedings and Interviews from a 2-Part CME Satellite Symposia Held at the 31st Annual San Antonio Breast Cancer Symposium. Case: 47-year-old postmenopausal woman with a 1.8-cm, ER/PR-positive, HER2-negative, node-negative BC who developed bone metastases after four years of an adjuvant aromatase inhibitor. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/SABCS_2008 – Second Opinion: Proceedings and Interviews from a 2-Part CME Satellite Symposia Held at the 31st Annual San Antonio Breast Cancer Symposium. Case: 76-year-old woman with a 0.8-cm, ER/PR-positive, HER2-negative, moderately differentiated IDC with two positive nodes and an Oncotype DX® Recurrence Score® of 13. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/SABCS_2008 – Second Opinion: Proceedings and Interviews from a 2-Part CME Satellite Symposia Held at the 31st Annual San Antonio Breast Cancer Symposium. Case: 76-year-old woman who underwent a mastectomy for a 6-cm, ER/PR-positive, HER2-positive, T4b IDC with skin ulceration and extensive dermal involvement. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/SABCS_2008 – Second Opinion: Proceedings and Interviews from a 2-Part CME Satellite Symposia Held at the 31st Annual San Antonio Breast Cancer Symposium. Case: 41-year-old woman with a 1.8-cm, triple-negative, node-negative IDC, longstanding Type 1 diabetes and recent retinopathy. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/SABCS_2008 – Second Opinion: Proceedings and Interviews from a 2-Part CME Satellite Symposia Held at the 31st Annual San Antonio Breast Cancer Symposium. Case: 67-year-old woman with a 2.5-cm, ER/PR-positive, HER2-negative, node-negative IDC who has completed five years of adjuvant anastrozole. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/SABCS_2008 – Second Opinion: Proceedings and Interviews from a 2-Part CME Satellite Symposia Held at the 31st Annual San Antonio Breast Cancer Symposium. Case: A 37-year-old woman with a 0.4-cm, moderately differentiated, ER/PR-negative, HER2-positive, node-negative IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.